Answer to “Comment on the article: “Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults””

Authors

  • Yuline Varela-Vega Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No.17 “Legaria”, Servicio de Atención Médica Continua. Ciudad de México, México https://orcid.org/0000-0002-0426-763X
  • Ivonne Analí Roy-García Instituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, División de Investigación Clínica. Ciudad de México, México https://orcid.org/0000-0002-1859-3866
  • Marcela Pérez-Rodríguez Instituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, División de Investigación Clínica. Ciudad de México, México https://orcid.org/0000-0003-3417-3201
  • Lubia Velázquez-López Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades “Dr. Bernardo Sepúlveda Gutiérrez”, Servicio de Admisión Continua. Ciudad de México, México https://orcid.org/0000-0002-1189-3399

DOI:

https://doi.org/10.5281/zenodo.14616836

Keywords:

Research, Diabetes Mellitus, Type 2, Sensitivity and Specificity, FINDRISC

Abstract

The FINDRISC instrument has been established as a screening tool to determine the risk of developing type 2 diabetes (T2D) at 10 years. However, the established cut-off points were based on a population with a low prevalence of the disease, unlike the Mexican population in which, based on the latest ENSANUT 2022 report, the global prevalence of T2D is 18.3%. Based on this, the need arose to establish a cut-off point to identify the presence of insulin resistance in this population using the FINDRISC instrument. And, in this way, iden­tify the population one step before the development of T2D.

Downloads

Download data is not yet available.

References

Varela-Vega Y, Roy-García IA, Pérez-Rodríguez M, et al. Certeza diagnóstica del instrumento FINDRISC para identificar resistencia a la insulina en adultos. Rev Med Inst Mex Seguro Soc. 2023;61(1):33-41.

Villalobos A, Rojas-Martínez R, Aguilar-Salinas CA, et al. Medical care and self-care actions in people living with diabetes, according to socioeconomic level. Salud Publica Mex. 2019;61(6):876-87.

Lindström J, Lindström L, Tuomilehto J. The Diabetes Risk Score A practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725-31. Disponible en: http://diabetesjournals.org/care/article-pdf/26/3/725/665299/dc0303000725.pdf.

American Diabetes Association. Standards of Care in Diabetes-2024. Diabete Care. 2024;47(1). Disponible en: https://diabetesjournals.org/care.

Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, et al. Prevalence of prediabetes and diabetes in Mexico: Ensanut 2022. Salud Publica Mex. 2023;65(1): 163-8.

INEGI. ESTADÍSTICA DE DEFUNCIONES REGISTRADAS (EDR). De enero a junio de 2023 (preliminar). 2023.

Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez- Bello D, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23-33.

Papakonstantinou E, Oikonomou C, Nychas G, et al. Effects of Diet, Lifestyle, Chrononutrition and Alternative Dietary Interventions on Postprandial Glycemia and Insulin Resistance. Nutrients. 2022;14(4):1-78.

Mirabelli M, Chiefari E, Arcidiacono B, et al. Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients. 2020;12(4):1-37.

García-Alcalá H, Genestier-Tamborero CN, Hirales-Tamez O et al. Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla city, Mexico. Diabetes, Metabolic Syndrome and Obesity. 2012;5:403-6.

Downloads

Published

2025-03-01

Issue

Vol. 63 No. 2 (2025): March-April

Section

Letter to the Editor

License

Copyright (c) 2025 Revista Médica del Instituto Mexicano del Seguro Social

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.